Critical insights to COVID-19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology
Pharmacol Res Perspect
.
2022 Feb;10(1):e00918.
doi: 10.1002/prp2.918.
Authors
Jennifer H Martin
1
,
Richard J Head
2
Affiliations
1
The University of Newcastle Hunter Medical Research Institute, New Lambton, New South Wales, Australia.
2
Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.
PMID:
35106934
PMCID:
PMC8929325
DOI:
10.1002/prp2.918
No abstract available
Publication types
Editorial
Comment
MeSH terms
COVID-19*
Humans
Pharmacology, Clinical*
SARS-CoV-2
Systems Analysis